Silo Pharma Enters Joint Development Agreement for SP-26 Ketamine Implant Device Targeting Pain Management


Prototype development and feasibility testing underway for optimized subcutaneous delivery

Go here to read the rest:
Silo Pharma Enters Joint Development Agreement for SP-26 Ketamine Implant Device Targeting Pain Management

Related Posts